7096
StemCell Institute
ステムセル研究所
- Industry
- Services
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Consolidation basisConsolidated / Since Mar 2026
- Stock adjustmentsJan 1, 2023 Stock split 1 share → 2 shares
Key metrics
Revenue(thousand JPY)
Mar 2022
1,781,943
Mar 2023
2,091,293
Mar 2024
2,481,193
Mar 2025
2,679,175
Mar 2026
2,811,344
Operating profit(thousand JPY)
Mar 2022
226,952
Mar 2023
297,560
Mar 2024
413,759
Mar 2025
418,509
Mar 2026
202,657
Operating profit margin(%)
Mar 2022
12.74
Mar 2023
14.23
Mar 2024
16.68
Mar 2025
15.62
Mar 2026
7.21
Profit before tax(thousand JPY)
Mar 2022
212,554
Mar 2023
278,957
Mar 2024
441,327
Mar 2025
565,712
Mar 2026
217,786
Profit(thousand JPY)
Mar 2022
133,726
Mar 2023
198,032
Mar 2024
310,981
Mar 2025
385,796
Mar 2026
155,917
Total assets(thousand JPY)
Mar 2022
5,215,602
Mar 2023
5,811,615
Mar 2024
6,543,075
Mar 2025
7,500,939
Mar 2026
8,124,841
Cash and cash equivalents(thousand JPY)
Mar 2022
3,510,318
Mar 2023
3,324,021
Mar 2024
2,845,540
Mar 2025
3,200,846
Mar 2026
2,834,134
Cash flows from operating activities(thousand JPY)
Mar 2022
469,290
Mar 2023
99,672
Mar 2024
334,625
Mar 2025
467,685
Mar 2026
73,509
Cash flows from investing activities(thousand JPY)
Mar 2022
404,170
Mar 2023
-285,100
Mar 2024
-811,773
Mar 2025
-259,084
Mar 2026
-744,565
Cash flows from financing activities(thousand JPY)
Mar 2022
644,373
Mar 2023
-869
Mar 2024
-1,333
Mar 2025
146,704
Mar 2026
231,558
Return on equity(%)
Mar 2022
7.81
Mar 2023
9
Mar 2024
12.46
Mar 2025
14.5
Mar 2026
5.81
Equity ratio(%)
Mar 2022
40.34
Mar 2023
39.55
Mar 2024
41.15
Mar 2025
35.03
Mar 2026
33.01
Earnings per share(JPY per share)
Mar 2022
13.205
Mar 2023
19.33
Mar 2024
30.35
Mar 2025
37.67
Mar 2026
15.44
Net assets per share(JPY per share)
Mar 2022
205.335
Mar 2023
224.33
Mar 2024
262.78
Mar 2025
258.35
Mar 2026
266.34
Dividend per share(JPY per share)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
25
Mar 2026
-
Payout ratio(%)
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
66.37
Mar 2026
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.